维普期刊资源整合服务平台（V6.5）

230篇 您的检索式：作者名="LANGE E D"

选中清除导出查看参考文献查看引证文献引用追踪共12页首页上一页第1页下一页末页 /12 跳转

	题名	作者	年代	出处	被引量
1	CD133,a novel marker for human prostatic epithelial stem cells显示文摘	Richardson G D Robson C N Lang S H Neal D E Maitland N J Collins A T	2004	J Cell Sci2004，117，16：	1
2	KRAS status and efficacy in the first-line treatment of patients with metastatic colorectal cancer (mCRC) treated with FOLFIRI with or without cetuximab:The CRYSTAL experience显示文摘	Van Cutsen E Lang I D'Haens G	2008	J Clin Oncol2008，26，5：	1
3	Beyond Megalopolis:Exploring America's New 'Megapllitan 'Geography显示文摘	R E Lang D Dhavale		0，，01：	1
4	Reduction of isofluraneminimal alveolar concentration by remifentanil显示文摘	Lang E Kaplia A Shlugman D	1996	Anesthesiology1996，85，4：	1
5	KRAS status and ef- ficacy in the first-line treatment of patients with metastatic color- ectal cancer treated with FOLFIRI with or without cetuximab: the CRYSTAL experience显示文摘	Van Custem E Lang I D' haens G	2008	J Clin Oncol2008，26，：	1
6	The physcomitrella genome reveals evolutionary insights into the conquest of land by plants 显示文摘	Rensing S A Lang D Zimmer A D Terry A Salamov A Shapiro H Nishiyama T Perroud P F Lindquist E A Kamisugi Y	2008	Science2008，319，5859：	1
7	Reduction of isoflurane minimal alveolar concentration by remifentanil显示文摘	Lang E Kaplia A Shlugman D	1996	Anesthesiology1996，85，：	1
8	Reduction of isoflurane minimum alveolar concentration by rermifentanil显示文摘	Lang E Kapila A Shlugnan D	1996	Anesthesiology1996，85，：	1
9	Cellular hydration state:an important determinant of protein catabolism in health and disease显示文摘	Haussinger D Roth E Lang F	1993	Lancet1993，341，8856：	1
10	KRAS status and efficacy in the firstline treatment of patient with metastatic coloreetal caneer (mCRC) treated with FOLFIRI with or without eetuximab: The CRYSTAL experience 显示文摘	Van Cutsem E Lang L D haens G	2008	J Clin Oneol2008，，：	1
11	KRAS status and efficacy in the first -line treatment of patients with metastatic colorectal cancer (mCRC) treated with FOLFIRI with or without cetuximab: the CRYSTAL experience 显示文摘	Van Cutsem E Lang I D' haens G Moiseyenko V Zaluski J Fol- precht G	2008	J Gin Oncol2008，2620，2：	1
12	Fracture behavior of low density fibrous ceramics显示文摘	GREEN D J RITTER J E LANGE F F	1982	J Am Ceram Soc1982，65，3：	1
13	Slowing down of the global accumulation of atmospheric CH4 during the 1980's 显示文摘	Steele L P D lugokencky E J Lang P M	1992	Nature1992，358，：	1
14	Reduction of isoflurane minimal alveolar concentration by remifentanil显示文摘	Lang E Kaplia A Shlugman D	1996	Anesthesiology1996，85，4：	1
15	Effect of converting enzyme in- hibitors on tissue converting enzyme and angiotensin Ⅱ : thera- peutic implications 显示文摘	Unger T Ganten D Lang R E	1987	Am J Cardiol1987，59，10：	1
16	DNA ploidy assessment method applied to primary breast carcinoma FNA biopsies 显示文摘	Lange D Chmielik E	2002	Folia Histochem Cytobio l2002，40，2：	1
17	MMP12,lung function, and COPD in high risk populations 显示文摘	Hunninghake G M Cho M H Tesfaigzi Y Soto - Quiros M E Avila L Lasky - Su J Stidley C Melen E Soderhall C Hallberg J Kull I KercJ Svartengren M Pershagen G Wickman M Lange C Demeo D L Hersh C P Klanderman B J Raby B A Sparrow D Shapiro S D Silverman E K Litonjua A A Weiss S T Celedon J C	2009	New England Journal of Medicine2009，361，27：	1
18	KRAS status and efficacy in the first-line treatment of patients with metastatic colorectal cancer(mCRC) treated with FOLFIRI with or without cetuximab: The CRYSTAL experience 显示文摘	Van Cutsem E Lang I D'haens G	2008	J Clin Oncol2008，26，15：	1
19	The Origin of Acoustic Noise in Variable-Reluctance Motors显示文摘	Cameron D E Lang J H Umans S D	1989	Proc of IEEE IAS Annual Meeting1989，28，6：	1
20	'l'he high-irequency response oI a plate carrying a concentrated mass/spring system显示文摘	Dowell E i-i lang D	1998	Journal of Sound and Vibration1998，213，5：	1

返回顶部每页显示：

共12页首页上一页第1页下一页末页 /12 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示